Shaun Pennington

We are delighted to announce at @ThePandemicInst our recent collaboration with @HPRUezi @PSIOxford @UKHSA to award £500k for research to combat #BirdFlu. It will be distributed across 8 projects from orgs including @LSTMnews @LivUni @PSIOxford 👇 thepandemicinstitute.org/news/500k-awar…

Calling all DTM&H Alumni! Registration's OPEN for LSTM's DTM&H Alumni Weekend (June 7-8)! Reconnect, hear inspiring talks & delve into the latest advancements! Limited space - register NOW: events.lstmed.ac.uk/dtmh-weekend #LSTM125 #LSTMAlumi

Massive credit and kudos to @PriyaDPatel5, the diligent dynamo behind this important result, online in the Lancet today. Typhoid Conjugate Vaccines give durable protection for at least 4 years, across all age-groups from 9 months to 12 years old. thelancet.com/journals/lance…

Our fully-funded, four-year MRC Doctoral Training Partnership (DTP) and iCASE studentships, are open to applicants for an October start. The deadline for stage 1 applications is Sunday 21st January 2024. Find out more and apply online: lstm.ac/MRC-DTP

Looking for a PhD in Immunology? @DanielaVaccines and I have a fully funded studentship available! A really exciting opportunity to study trained immunity through controlled human infection - take a look here: bit.ly/3R6EqcA Come and join the team! 🥼🧫🔬🦠

The excitement is building for this evening's #THEAwards! Honoured to be shortlisted for 'University of the Year', an achievement that speaks volumes about our impact as a small, specialist research institution. Wishing luck to the other nominees as we await the big reveal.

We conducted a combined analysis of the now 8 trials that studied the effect of BCG vaccine against COVID-19 and other respiratory infections in health care workers and elderly. BCG was associated with a 39% (3-62%) reduction in all-cause mortality #NSEvac nejm.org/doi/full/10.10…

Guest editing a Special Issue of @MDPIOpenAccess Vaccines, entitled 'Advances in Oral Vaccine Development'! Please circulate amongst your networks! 🦠🧫💊🔬 mdpi.com/journal/vaccin…

Interested in a PhD from @LSTMnews? Lots of fully-funded opportunities here... take a look!

NC3Rs project grant holder @stuains is organising a free online meeting to discuss the current snake venom lethality murine model, and potential improvements/new models. 📅26 January 2023 Register now: eventbrite.co.uk/e/improving-in…

Had a fantastic time presenting at the #WorldVaccineCongress on behalf of @InvestLiverpool. Really enjoyed talking about some of the fantastic work being undertaken @LSTMnews and @iiconNW! #VaccineDevelopment #DrugDevelopment

Great start to @ELRIG_UK Drug Discovery 2022. Nice to talk research and check out all the new #DrugDiscovery technology! #ELRIG

Great turnout and discussions for today's @UK_NPAW #NPAW2022 event at @LSTMnews on traditional academic and alternative career pathways for ECRs. Thank you to all our panelists and chairs (listed below) ☺️ #LovePostdocs

We have a new Dr in the house! - Many congratulations to Dr Emmanuel Moyo for passing his PhD viva with flying colours!!👏👏👏Emanuel's thesis focused on the pharmacology of novel fluroquinolones against TB as well as looking at drug resistance evolution @LSTMnews @CDD_LSTM

#FluorescentFriday! #Alveolar #epithelial cell (@LonzaGroup) cocultures grown using PhysioMimix #OrganOnAChip to recapitulate in vivo alveoli by @BioChemily.Learn about about our #COVID19 collaboration with @iiconNW led by @LSTMnews funded by @innovateuk bit.ly/3Dzjlje

Just finally established SARS-CoV-2 live imaging at @LSTMnews. The ultimate tool offering endless possibilities. Exciting times ahead! Watch how these cells turn red when infected 🤯🔴🦠 More awesome videos the come..! #SARSCoV2 #COVID19 #Microscopy

@jay_salsa @GiancarloBiagi4 Brilliant news! Congratulations, @jay_salsa!

Congratulations @jay_salsa !

@GrahamWhittle88 @F1 @netflix Always a good watch 👍🏻

@F1 @netflix @ShaunPennington

Season 3. March 19. #F1 @netflix

New, funded #PhD opportunity for a #chemist who would like to develop skills in #microbiology and tackle #AMR; Developing novel metallo-beta-lactamase inhibitors against resistant bacteria @LivUni @LSTMnews findaphd.com/phds/project/d…

Antibody response to the 1st vaccine dose in individuals with pre-existing immunity corresponds to that in naïve individuals after the 2nd dose; those with immunity got significantly more side effects. It seems obvious to drop (at least) the 2nd dose. medrxiv.org/content/10.110…